EPIRUBICIN - A REVIEW OF THE PHARMACOLOGY, CLINICAL ACTIVITY, AND ADVERSE-EFFECTS OF AN ADRIAMYCIN ANALOG

被引：230

作者：

CERSOSIMO, RJ

HONG, WK

机构：

[1] VET ADM MED CTR JAMAICA PLAIN,BOSTON,MA 02130

[2] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,HEAD & NECK MED ONCOL SECT,HOUSTON,TX 77030

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1986年 / 4卷 / 03期

关键词：

D O I：

10.1200/JCO.1986.4.3.425

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：425 / 439

页数：15

共 103 条

[71]

PANNUTI F, 1984, INT S ADV ANTHRACYCL, P48

[72]

PANNUTI F, 1984, ADV ANTHRACYCLINE CH, P165

[73]

PARRY H, 1982, INT S ADV ANTHRACYCL, P433

[74]

PAVONE-MACALUSO M, 1976, European Urology, V2, P138

[75]

PAVONEMACALUSO MP, 1983, 13TH P INT C CHEM, V240, P114

[76]

PERGOLA M, 1984, INT S ADV ANTHRACYCL, P42

[77] STUDIES ON MODE OF INTERACTION OF 4'-EPI-ADRIAMYCIN AND 4-DEMETHOXYDAUNOMYCIN WITH DNA [J].

PLUMBRIDGE, TW ;

BROWN, JR .

BIOCHEMICAL PHARMACOLOGY, 1978, 27 (14) :1881-1882

[78] RANDOMIZED PHASE-II TRIAL OF CARMINOMYCIN VERSUS 4'-EPIDOXORUBICIN IN ADVANCED BREAST-CANCER [J].

ROZENCWEIG, M ;

HUININK, WT ;

CAVALLI, F ;

BRUNTSCH, U ;

DOMBERNOWSKY, P ;

HOST, H ;

BRAMWELL, V ;

RENARD, G ;

VANGLABBEKE, M ;

DECOSTER, G ;

CLARYSSE, A .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (04) :275-281

[79]

ROZENCWEIG M, 1983, 13TH P INT C CHEM, V215, P17

[80]

SCHEIN PS, 1978, CANCER, V42, P19, DOI 10.1002/1097-0142(197807)42:1<19::AID-CNCR2820420103>3.0.CO

← 2 3 4 5 6 7 8 9 10 11 →